Luorui Shang

914 total citations · 2 hit papers
16 papers, 582 citations indexed

About

Luorui Shang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Luorui Shang has authored 16 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Luorui Shang's work include Inflammasome and immune disorders (5 papers), Respiratory Support and Mechanisms (4 papers) and interferon and immune responses (2 papers). Luorui Shang is often cited by papers focused on Inflammasome and immune disorders (5 papers), Respiratory Support and Mechanisms (4 papers) and interferon and immune responses (2 papers). Luorui Shang collaborates with scholars based in China, Vietnam and South Africa. Luorui Shang's co-authors include Shenglan Yang, Fangyuan Zhou, Guangtao Pan, Yuhan Liu, Jinxiao Li, Shuhan Wang, Mengqi Zhang, Yuhan Liu, Kunmin Xiao and Fangyuan Zhou and has published in prestigious journals such as Frontiers in Immunology, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Luorui Shang

14 papers receiving 576 citations

Hit Papers

EMT‐associated microRNAs and their roles in cancer stemne... 2021 2026 2022 2024 2021 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
    2021 246 citations Guangtao Pan, Yuhan Liu et al. Cancer Communications profile →
  2. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation
    2022 161 citations Luorui Shang, Jinxiao Li et al. Journal of Ethnopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luorui Shang China 9 341 166 96 75 71 16 582
Shenglan Yang China 9 412 1.2× 172 1.0× 93 1.0× 75 1.0× 102 1.4× 14 702
Xinxing Li China 15 264 0.8× 92 0.6× 141 1.5× 40 0.5× 46 0.6× 31 561
Young‐Joo Jeon South Korea 16 343 1.0× 92 0.6× 71 0.7× 49 0.7× 29 0.4× 36 609
Peiwu Li China 17 309 0.9× 175 1.1× 78 0.8× 45 0.6× 114 1.6× 37 659
Qingling Li China 11 186 0.5× 80 0.5× 77 0.8× 58 0.8× 46 0.6× 40 515
Hsiao‐Fan Chen Taiwan 14 358 1.0× 158 1.0× 127 1.3× 27 0.4× 56 0.8× 22 640
Gaoxiang Ma China 13 332 1.0× 63 0.4× 44 0.5× 48 0.6× 39 0.5× 33 612
Xin Su China 14 280 0.8× 143 0.9× 63 0.7× 23 0.3× 104 1.5× 37 544
Weiming He China 13 285 0.8× 115 0.7× 49 0.5× 53 0.7× 54 0.8× 46 663

Countries citing papers authored by Luorui Shang

Since Specialization
Citations

This map shows the geographic impact of Luorui Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luorui Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luorui Shang more than expected).

Fields of papers citing papers by Luorui Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luorui Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luorui Shang. The network helps show where Luorui Shang may publish in the future.

Co-authorship network of co-authors of Luorui Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Luorui Shang. A scholar is included among the top collaborators of Luorui Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luorui Shang. Luorui Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Shang, Luorui, et al.. (2025). Macrophage pyroptosis and its crucial role in ALI/ARDS. Frontiers in Immunology. 16. 1530849–1530849. 6 indexed citations
2.
Chen, Liuying, Zhongwei Yin, Luorui Shang, et al.. (2025). Intestinal Fut2 deficiency exacerbated alcohol‐related liver disease by disrupting nicotinamide metabolism. Clinical and Translational Medicine. 15(8). e70447–e70447. 1 indexed citations
3.
Zhou, Fangyuan, et al.. (2025). Ellagic acid mediated pyroptosis in hepatocellular carcinoma via the ESR1/G6PD pathway. Biochemical Pharmacology. 241. 117178–117178.
4.
Zhou, Fangyuan, Luorui Shang, Jinxiao Li, et al.. (2025). Erianin reverses 5-FU resistance by targeting CALM1/CAMKK2 and activating autophagy in colorectal cancer. Chemico-Biological Interactions. 421. 111750–111750.
5.
Shang, Luorui, et al.. (2025). Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS. APOPTOSIS. 30(11-12). 2547–2587. 1 indexed citations
6.
Shang, Luorui, Jinbo Xie, Tao Zhou, et al.. (2025). Current status and trend of global research on the pharmacological effects of emodin family: bibliometric study and visual analysis. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(6). 6165–6178. 1 indexed citations
7.
Shang, Luorui, Cuiling Liu, Chengyi He, et al.. (2024). Corilagin inhibits human cytomegalovirus infection and replication via activating the cGAS-STING signaling pathway in vitro and in vivo. International Immunopharmacology. 143(Pt 2). 113401–113401. 1 indexed citations
8.
Zhang, Mengqi, Luorui Shang, Fangyuan Zhou, et al.. (2024). Dachengqi decoction dispensing granule ameliorates LPS-induced acute lung injury by inhibiting PANoptosis in vivo and in vitro. Journal of Ethnopharmacology. 336. 118699–118699. 10 indexed citations
9.
Shang, Luorui, Jinxiao Li, Fangyuan Zhou, et al.. (2023). MiR-874-5p targets VDR/NLRP3 to reduce intestinal pyroptosis and improve intestinal barrier damage in sepsis. International Immunopharmacology. 121. 110424–110424. 8 indexed citations
10.
Shang, Luorui, Mengqi Zhang, Jinxiao Li, et al.. (2023). Dachengqi decoction alleviates acute lung injury by suppressing HIF-1α-mediated glycolysis. Journal of Ethnopharmacology. 321. 117410–117410. 9 indexed citations
11.
Li, Jinxiao, Luorui Shang, Fangyuan Zhou, et al.. (2023). Herba Patriniae and its component Isovitexin show anti-colorectal cancer effects by inducing apoptosis and cell-cycle arrest via p53 activation. Biomedicine & Pharmacotherapy. 168. 115690–115690. 19 indexed citations
12.
Zhou, Fangyuan, Haiyang Gao, Luorui Shang, et al.. (2023). Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 150–150. 51 indexed citations
13.
Shang, Luorui, Jinxiao Li, Fangyuan Zhou, et al.. (2022). Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. Journal of Ethnopharmacology. 302(Pt A). 115876–115876. 161 indexed citations breakdown →
14.
Li, Jinxiao, Fangyuan Zhou, Luorui Shang, et al.. (2022). Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer via CDK1/PI3K/Akt signaling. Frontiers in Oncology. 12. 961653–961653. 11 indexed citations
15.
Pan, Guangtao, Yuhan Liu, Luorui Shang, Fangyuan Zhou, & Shenglan Yang. (2021). EMT‐associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Communications. 41(3). 199–217. 246 indexed citations breakdown →
16.
Zhou, Fangyuan, Meihui Tao, Luorui Shang, et al.. (2021). Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis. Frontiers in Medicine. 8. 717194–717194. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shenglan Yang Breakdown of academic impact, for papers by Xinxing Li Breakdown of academic impact, for papers by Young‐Joo Jeon Breakdown of academic impact, for papers by Peiwu Li Breakdown of academic impact, for papers by Qingling Li Breakdown of academic impact, for papers by Hsiao‐Fan Chen Breakdown of academic impact, for papers by Gaoxiang Ma Breakdown of academic impact, for papers by Xin Su Breakdown of academic impact, for papers by Weiming He
Rankless by CCL
2026